Thus, both can inhibit the expression of intracellular markers (MAP kinase, cyclin D2, Akt phosphorylation), and promote the expression of proliferation inhibitors or apoptotic markers (p21, p27) in ovarian granulosa and ovarian cancer cells (13, 93, 101). The gene discussed is AKT1; the disease is ovarian carcinoma.